Theorem Clinical Research Expands Partnership with Medidata Solutions - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Theorem Clinical Research Expands Partnership with Medidata Solutions

Source: Company News Release
Theorem Clinical Research, a contract research organization that optimizes trial conduct, recently expanded its Medidata partnership by obtaining accreditation for Medidata Patient Cloud.

This accreditation enables Theorem to provide a unified approach to capture data directly from patients. Clinical investigators and sponsors will gain operational efficiencies with immediate access to review electronic patient reported outcomes (ePRO) data in one platform while leveraging Theorem’s clinical expertise.

“We will be able to transform what can be a lengthy and expensive process into a fast implementation using Medidata’s platform of cloud-based solutions, which includes capabilities to facilitate direct communication with patients,” said Mark Penniston, executive vice president and general manager for clinical analytics.

“Theorem shares our vision of bringing the voice of the patient into clinical research and positively transforming the clinical trial experience for all study participants,” said Steve Heath, Medidata’s vice president of channel sales. “This accreditation reinforces Theorem’s commitment to leveraging innovative technology to accelerate the delivery of medicine to patients around the world.”

Theorem has built hundreds of studies in Medidata Rave and is a top holder of accreditations among Medidata Services Partners with accreditation in:
  • Medidata Rave
  • Medidata Rave Safety Gateway
  • Medidata Rave Targeted SDV
  • Medidata BalanceRandomization

Theorem clinical analytics experts will deliver two presentations during the Medidata Symposium 2014 April 23–25 in San Francisco:
  • Impact Analysis – Key Considerations Before Making Post-Production Changes, presented by April Bebee and Beatrice Clark
  • Targeted SDV (TSDV) Lessons Learned, presented by Vicken Yanikian

Additionally, innovative solutions will be featured during the symposium in the Innovation Lounge, including automation of mapping from Medidata Rave into CDISC-compliant data sets via SAS CDI and real-time data visualizations from Medidata Rave to Spotfire visual analytics.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document
Source: Company News Release,
Click here